RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial

... post-marketing multi- center, randomized, blinded comparative study of nasolabial fold treatments reporting ... reach full correction in this split-face trial comparative trial. In conclusion, the study authors noted ... Restylane Clinical Trial A 60-patient blinded, comparative split-face study was conducted at two clinical ...

Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery

... of a multi-center, randomized, blinded comparative study of nasolabial fold treatments reporting ... filler options. The published report of the comparative study of Radiesse against leading hyaluronic acid ... and Perlane Clinical Trial A 205-patient comparative study was conducted at five clinical sites ...

New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation

... treat a type of irregular heartbeat known as atrial fibrillation. The new comparative effectiveness report found that the procedure has been shown to provide ... . AHRQ's new report, comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation, ...

New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer

... and one of the study researchers. "It's also the first time that a comparative analysis has been done looking at various SSRIs and what's clear is that ... CYP2D6 inhibitor drugs are present, and it is the first study to show the comparative impact of various antidepressants on breast cancer recurrence. "While ...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

... administration in less than 2.5 minutes. IsoCrom & ICS comparative Study Results Data from a randomized, open-label, Phase II, six-month ... treatment with either inhaled corticosteroids or IsoCrom. PARI's comparative in-vitro assessment of IsoCrom & a novel 6% DSCG formulation ...

Virtual Colonoscopies Show Value for Some Patients, But Polyps Will Be Missed

... best approaches to improving patient care, analyzed recent studies on the comparative effectiveness of CT colonography to traditional colonoscopy. Researchers ... Assessment Information Service(TM), or for information about other comparative effectiveness reviews and health technology assessment services , e-mail ...

The Quigley Corporation Licenses Naturally Derived Compound For Scar Improvement; License Requires Payments Totaling $1.1 Million To The Quigley Corporation Over A Five Year Period For Exclusive Ownership

... been clinically tested and shown to improve the appearance of scars in a comparative study. The Agreement is with Levlad, LLC/Natures Gate, ... this compound showed an improvement in the visual appearance of scars in a comparative study versus a category leading OTC national brand name scar cream. ...

Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association

... Supports Phase 2 REVEAL-1 Trial Researchers presented an analysis of comparative safety, pharmacokinetic and response data from Sunesis' Phase 1 ... that can be tolerated by older patients remains unmet. Results from our comparative analysis demonstrate that voreloxin is generally well tolerated and ...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

... WARSAW, Ind., July 20 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) today announced that data from a comparative clinical study conducted by researchers at the Mayo Clinic and the Joint Replacement Surgeons of the Indiana Research Foundation describes the low ...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

... (SNP) genotyping and allelotyping, copy number variation analysis, quantitative gene expression analysis, quantitative methylation marker analysis, comparative sequence analysis of haploid organisms, SNP discovery, and oligonucleotide quality control. About SEQUENOM SEQUENOM is a life sciences ...

Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative

... A mission-driven, values-based organizational culture brings people together to achieve higher performance. Clinical dashboards communicate comparative physician performance. Performance-based pay rewards achievement on quality, patient satisfaction, productivity, and engagement. ...

Spherix Announces Positive Phase 2 Study Results

... Diabetes Type 2 diabetes mellitus (T2DM) is a disease that is characterized by elevated blood glucose in the context of insulin resistance and comparative insulin deficiency. While T2DM is often initially managed by increasing exercise in conjunction with dietary modification, medications are usually ...

Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting

... The microfracture technique is the current standard for articular cartilage treatment. The second study, performed in collaboration with the comparative Orthopaedic Research Laboratory at the New Bolton Center of the University of Pennsylvania School of Veterinary Medicine , examined the CRD in a ...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

... of Cinryze in Pigs From the laboratory of Dr. Michael Frank at Duke University , Dr. H. Jiang et al. described the results of a comparative pharmacokinetic study of subcutaneous and intravenous doses of C1 Inhibitor in an abstract entitled, 'Subcutaneous (SQ) Versus Intravenous (IV) ...

NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative Technology

... is a minimally invasive treatment for patients suffering with symptomatic varicose veins and venous reflux, and has been demonstrated in numerous comparative studies to offer advantages over conventional vein stripping surgery. The technique will be showcased at the NHS EXPO Meeting on June 18-19, 2009. ...

Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study

... a weight gain of 7.4 pounds for pioglitazone. "Recognizing the importance of A1C control, it has become clear that health care providers need comparative data to better understand the relative value of therapeutic options," said Richard Bergenstal, M.D., executive director of the International Diabetes ...

AHRQ-Funded Study Finds Lower Risk of Death and Heart Attack in Patients With Drug-Coated Stent Implants Compared to Those With Bare Metal Stents

... supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology's National Cardiovascular Data Registry. The comparative effectiveness study of 262,700 Medicare patients who received stents - spring-like tubes to keep heart vessels open - is the largest ever to compare ...

Astrocytes Help Separate Man From Mouse

... Ph.D., professor and chair of Neurology; Webster Pilcher, M.D., professor and chair of Neurosurgery; Jeffrey Wyatt, D.V.M., professor and chair of comparative Medicine; and research assistant professors Takahiro Takano, Ph.D., Xiaoning Han, Ph.D., Wei He, Ph.D., and Fushun Wang, Ph.D. Other authors ...

Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State

... (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that its ClariSure(TM) microarray-based comparative genomic hybridization (aCGH) postnatal test is now available for testing on patients in the state of New York. With licensure by the State Department ...

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

... CUR) made synaptic contacts with the motor neurons of rats with ALS-like symptoms, a paper published in the current online edition of the Journal of comparative Neurology reported. This constitutes evidence that the transplanted cells integrated into the nervous system of the host. The rats had a genetic ...

Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmer's Trabecular Metal(TM) Technology

... ZMH ; SWX: ZMH), a leader in the orthopaedic industry, today announced that data from an independent 10-year Trabecular Metal (TM) Technology comparative clinical study demonstrates the osteoconductive properties of Zimmer's Trabecular Metal Technology. The study found bone-to-implant gap-filling ...

Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery

... The other three treatment arms remained blinded. Subsequent analyses were designed to estimate the extent to which the crossover affected the comparative benefit of Femara(1). With the long-term follow-up in the analysis conducted more than 10 years after the start of the study, adverse events ...

Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome

... that can lead to renal failure if not controlled. The primary objective of the multi-center, open-label, randomized, parallel group comparative study was to compare the adequacy of control of PUA concentration and the safety profile in three treatment arms. Among the three treatment arms, ...

Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful

... in least painful testing, we are helping to remove one of the barriers to adequate testing for improved diabetes management." The comparative pain study was conducted by Dr. Richard Koubek, of Koubek and Associates, on behalf of Roche. About Roche Diabetes Care Roche ...

Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials

... Triage Study (ALTS), the Cervista HPV high-risk test has a comparable specificity to the test used in that study. The ALTS trial is the best comparative trial for the Cervista HPV high-risk trial based on similarities in trial design. The Cervista HPV high-risk test has additional advantages ...

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting

... mg twice daily (21/23). uSSSI Phase 2 Trial Design This Phase 2 trial, which enrolled 150 patients, was a multicenter, randomized, open-label, comparative study conducted at 19 clinical centers across the U.S. to evaluate the safety and efficacy of radezolid versus linezolid in the outpatient treatment ...

Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections

... test-of-cure (TOC) visit (7 to 14 days post treatment) and at a late follow-up visit 7 to 14 days after the TOC visit. The primary endpoint was the comparative clinical cure rates of iclaprim and linezolid at the TOC visit in the ITT and PP populations. The most commonly reported adverse events in the ...

Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

... and Chemotherapy (ICAAC), taking place in Washington, D.C. Paratek's U.S.-based Phase 2 multi-center, randomized (1:1), investigator-blinded, comparative trial enrolled 234 patients with cSSSI who required initial IV therapy. Patients were randomized to receive up to 14-days of therapy of either PTK ...

Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia

... including penicillin, macrolide and quinolone resistant strains. The NXL103 Phase II study was a double-blind, multinational, randomized, comparative study that evaluated this novel oral antibacterial as a treatment for mild to moderate CAP. The study recruited 300 adult patients in 9 countries in ...

PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle

... Fellowship at the University of California, Los Angeles Medical School and clinical associate professor of surgery at UCLA. "The findings of this comparative preclinical study demonstrate that the PlasmaBlade Needle causes less thermal tissue damage than traditional electrosurgery because it cuts and ...

Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels

... insulin analogues are associated with a higher frequency of hypoglycemic events than oral antidiabetic (non-insulin) agents are. The report, comparative Effectiveness, Safety and Indications of Pre-mixed Insulin Analogues for Adults With Type 2 Diabetes, is available at effectivehealthcare.ahrq.gov. ...

Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis

... positive results announced for this vaccine in June 2008. The data were derived from a histopathological analysis of tissues samples collected in comparative studies of CEL-2000 and Enbrel(R) that were conducted in a well established animal model of rheumatoid arthritis. Enbrel is a leading treatment for ...

Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b

... by Daiichi Sankyo Company, Limited (TSE: 4568) and the data were presented by lead investigator Dr. Gary Raskob. This randomized, double-blind comparative study examined the safety and efficacy of four doses of DU-176b (15, 30, 60 and 90 mg once daily) versus the low molecular weight heparin, ....

TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet

... inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992; 117(3):234-42. (5) Matchar DB, et al. Systematic Review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med ...

Shingles Pain Treatment Will Benefit More Patients

... SMC decision (issued in February 2007) for Versatis (5% lidocaine medicated plaster) is based on significant new clinical and cost-effectiveness comparative data and brings prescribing availability of the treatment in line with England and Wales. These new data on Versatis will be presented for the first ...

Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma

... EVP, Chief Medical Officer of Cell Therapeutics. "A standard-of-care arm (doxorubicin) is included as a reference arm, although not used to determine comparative efficacy. If the study results are encouraging, a Phase III study in soft tissue sarcoma could be initiated in 2009." The title of the trial is ...

Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company

... profile to dosing with INS-19 as with Neupogen(R). These human INS-19 and Neupogen(R) data complement Insmed's extensive analytical testing and comparative data from pre-clinical assessments. "These results are very exciting, as they represent Insmed's ability to replicate a protein product, to bring ...

Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)

... 96-week comparative study of Clevudine versus Viread(R) versus Clevudine+Viread(R) in 150 patients with chronic hepatitis B PRINCETON, N.J., July 8 ...

Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections

... to building a robust antibiotic franchise." Design and Results The two globally conducted, multi-center, Phase III, randomized, double-blind comparative studies were designed to evaluate the efficacy and safety of ceftaroline compared to vancomycin plus aztreonam. The data were collected from 1396 ...

New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes

... also announced today the first and only full scale study of once-daily Levemir versus a single daily dose of glargine to generate the first robust comparative data set of the two treatments. "By finally establishing the efficacy profiles of these drugs in a direct and fair comparison, we will help ...